Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

100 trials found

Recruiting 100,000 target

International Weight Control Registry

Tufts University

NCT04907396

Recruiting NA 13,000 target

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Washington University School of Medicine

NCT05991453

Recruiting Phase 3 11,000 target

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Boehringer Ingelheim

NCT06531824

Recruiting 10,000 target

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Dana-Farber Cancer Institute

NCT02269592

Recruiting NA 8,946 target

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Dartmouth-Hitchcock Medical Center

NCT05612347

Recruiting NA 6,000 target

Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection

Trustees of Dartmouth College

NCT04600973

Recruiting 5,000 target

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

AtriCure

NCT05110989

Recruiting 5,000 target

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Yale University

NCT06030063

Recruiting NA 3,000 target

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Children's Hospital of Philadelphia

NCT05838690

Recruiting NA 2,448 target

Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients

Dartmouth-Hitchcock Medical Center

NCT06898593

Recruiting 2,000 target

The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System

Endologix

NCT06990048

Recruiting 2,000 target

Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain

AtriCure

NCT06908538

Recruiting NA 1,881 target

Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)

University of Pennsylvania

NCT06438640

Recruiting Phase 3 1,594 target

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

European Myeloma Network B.V.

NCT05243797

Recruiting 1,500 target

Immune Profiling for Cancer Immunotherapy Response

Dartmouth-Hitchcock Medical Center

NCT06116032

Recruiting NA 1,440 target

Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children

Johns Hopkins University

NCT04989790

Recruiting NA 1,200 target

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

Dartmouth-Hitchcock Medical Center

NCT05955339

Recruiting Phase 3 1,200 target

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT

Major Extremity Trauma Research Consortium

NCT04678154

Recruiting NA 1,100 target

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Population Health Research Institute

NCT04743765

Recruiting 1,065 target

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Merck Sharp & Dohme

NCT04165798

Recruiting NA 1,000 target

Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer

Alliance Foundation Trials

NCT06963723

Recruiting 1,000 target

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Abbott Medical Devices

NCT04071847

Recruiting 1,000 target

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

Lung Cancer Mutation Consortium

NCT04712877

Recruiting 1,000 target

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

SCAD Alliance

NCT04496687

Recruiting 900 target

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Ascendis Pharma Endocrinology Division A/S

NCT05820672

Recruiting Phase 3 770 target

Multi-Center Clean Air Randomized Controlled Trial in COPD

JHSPH Center for Clinical Trials

NCT06376994

Recruiting Phase 3 756 target

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Shanghai Junshi Bioscience Co.

NCT06095583

Recruiting Phase 3 740 target

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

Daiichi Sankyo

NCT05215340

Recruiting Phase 3 700 target

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Janssen Research & Development

NCT01804686

Recruiting NA 680 target

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

University of Colorado, Denver

NCT05753748

Recruiting Phase 3 670 target

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Iovance Biotherapeutics

NCT05727904

Recruiting Phase 3 600 target

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Janssen Research & Development

NCT06852222

Recruiting Phase 2 590 target

A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Bristol-Myers Squibb

NCT07063745

Recruiting Phase 3 540 target

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Daiichi Sankyo

NCT06203210

Recruiting Phase 1 540 target

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Eli Lilly and Company

NCT04956640

Recruiting 500 target

Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

Luminopia

NCT06429280

Recruiting 500 target

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Ascendis Pharma Endocrinology Division A/S

NCT05775523

Recruiting NA 500 target

Internet Based Psychological Support

Dartmouth-Hitchcock Medical Center

NCT02726061

Recruiting Phase 3 480 target

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Dianthus Therapeutics

NCT06858579

Recruiting Phase 3 470 target

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Regeneron Pharmaceuticals

NCT06149286

Recruiting Phase 1 450 target

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Merck Sharp & Dohme

NCT04165070

Recruiting NA 450 target

Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)

Annetine Gelijns

NCT05051033

Recruiting Phase 3 420 target

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Revolution Medicines

NCT06881784

Recruiting 420 target

Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling

Eric R. Henderson

NCT06877793

Recruiting Phase 3 420 target

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

AbbVie

NCT06810505

Recruiting NA 407 target

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Boston Scientific Corporation

NCT06735534

Recruiting Phase 2 400 target

Nectero EAST System Clinical Study

Nectero Medical

NCT06001918

Recruiting Phase 3 400 target

Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Boehringer Ingelheim

NCT07195695

Recruiting Phase 3 386 target

Improving Mobility After Revascularization in Peripheral Artery Disease

Northwestern University

NCT06686121

Recruiting Phase 2 375 target

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Dana-Farber Cancer Institute

NCT04569747

Recruiting Phase 3 352 target

Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures

Major Extremity Trauma Research Consortium

NCT06337292

Recruiting NA 336 target

The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults

Dartmouth-Hitchcock Medical Center

NCT05824572

Recruiting Phase 3 330 target

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Incyte Corporation

NCT06516965

Recruiting NA 330 target

Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early Life

Trustees of Dartmouth College

NCT06534541

Recruiting Phase 3 312 target

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

University of Maryland, Baltimore

NCT05615844

Recruiting 300 target

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

United Therapeutics

NCT05776225

Recruiting 300 target

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

Dana-Farber Cancer Institute

NCT04968834

Recruiting 300 target

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

Penumbra

NCT06747117

Recruiting Phase 1 300 target

The HALT Biomarker Study

Massachusetts General Hospital

NCT04552275

Recruiting NA 300 target

Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals

University of Florida

NCT06089239

Recruiting Phase 3 288 target

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

Novartis Pharmaceuticals

NCT06331312

Recruiting 260 target

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

University of Virginia

NCT06595420

Recruiting NA 250 target

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

University of California, San Diego

NCT05230173

Recruiting Phase 1 234 target

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Bristol-Myers Squibb

NCT06997029

Recruiting 220 target

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

American Laboratory Products Company

NCT06810518

Recruiting Phase 1 204 target

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

Dartmouth-Hitchcock Medical Center

NCT06134375

Recruiting NA 200 target

Women's Heart Attack Research Program: Stress Ancillary Study

NYU Langone Health

NCT02914483

Recruiting 200 target

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment

Ryan J. Halter

NCT06039085

Recruiting Phase 3 200 target

[18F]PI-2620 Phase 3 Histopathological Study

Life Molecular Imaging

NCT05641688

Recruiting Phase 2 192 target

CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth

Dartmouth-Hitchcock Medical Center

NCT05405413

Recruiting Phase 3 190 target

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

RenovoRx

NCT03257033

Recruiting NA 190 target

Neural Mechanisms of Interpersonal Expectations on Negative Affect

Trustees of Dartmouth College

NCT06980090

Recruiting NA 182 target

POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment

Medstar Health Research Institute

NCT06634459

Recruiting NA 180 target

AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion

Shape Memory Medical

NCT06029660

Recruiting NA 175 target

Human Intracranial Electrophysiology

Dartmouth-Hitchcock Medical Center

NCT05529264

Recruiting NA 173 target

Efficacy of the I-CARE Digital Health Intervention

Dartmouth-Hitchcock Medical Center

NCT07150832

Recruiting NA 172 target

Healthy Homes Study

Dartmouth-Hitchcock Medical Center

NCT05833334

Recruiting 165 target

Restoration of Thumb Strength and Function in Basal Joint Arthritis: A Comparative Effectiveness Trial (RESTART)

Dartmouth-Hitchcock Medical Center

NCT04458584

Recruiting Phase 2 150 target

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

Navigator Medicines

NCT07384975

Recruiting NA 150 target

The Warmth, Anticipation, Sensation, Aversion, and Body-part Imaging Study

Trustees of Dartmouth College

NCT04653064

Recruiting 150 target

Biliary Atresia Research Network Northeast

Yale University

NCT06184971

Recruiting NA 136 target

Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research

Dartmouth-Hitchcock Medical Center

NCT06838689

Recruiting Phase 2 135 target

Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

Dartmouth-Hitchcock Medical Center

NCT05933395

Recruiting Phase 1 132 target

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Conjupro Biotherapeutics

NCT05948865

Recruiting Phase 1 126 target

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

7 Hills Pharma

NCT06362369

Recruiting NA 126 target

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Northwestern University

NCT05987852

Recruiting NA 125 target

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

Dartmouth-Hitchcock Medical Center

NCT06930846

Recruiting 125 target

Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Dartmouth-Hitchcock Medical Center

NCT07201376

Recruiting NA 125 target

HOBSCOTCH-MS-Efficacy Trial

Dartmouth-Hitchcock Medical Center

NCT06951919

Recruiting Phase 1 123 target

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Daiichi Sankyo

NCT06362252

Recruiting 120 target

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

American Laboratory Products Company

NCT07089420

Recruiting NA 100 target

Nutrition to Support Postoperative Recovery

Dartmouth-Hitchcock Medical Center

NCT07109505

Recruiting 100 target

Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss

Dartmouth-Hitchcock Medical Center

NCT05107466

Recruiting NA 100 target

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

LimFlow

NCT05313165

Recruiting 100 target

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

Rachel A. Moses

NCT07368647

Recruiting NA 100 target

Self-discontinuation of Urinary Catheters in a Rural Population

Dartmouth-Hitchcock Medical Center

NCT07041151

Recruiting NA 95 target

Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release

Dartmouth-Hitchcock Medical Center

NCT06330545

Recruiting NA 95 target

Utility of CC7 Transfer in Stroke Subtypes

Dartmouth-Hitchcock Medical Center

NCT06001736

Recruiting Phase 3 90 target

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

Boehringer Ingelheim

NCT06624670

Recruiting NA 90 target

Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services

Dartmouth-Hitchcock Medical Center

NCT07195513

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →